B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Azithromycin

A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.

1,000 PubMed studies analyzed ยท 590 RCTs ยท Evidence Score: 74.7

Research Domains

Azithromycin has been studied across 11 research domains including ๐Ÿซ Respiratory, ๐Ÿ˜ด Sleep, ๐Ÿ”ฌ Inflammation, ๐Ÿฆ  Gut & Microbiome, ๐Ÿ›ก๏ธ Immunity. The primary research focus is ๐Ÿซ Respiratory with 17% of studies addressing this area.

Loading evidence profile...

This evidence profile for Azithromycin is generated deterministically from 1,000 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.